NHS England private patient units are too small to deal with private medical insurers. That is likely to be behind recent friction between NHS entities and private medical insurer Bupa.
Kry, the Swedish-based multinational telehealth and primary care unicorn, is laying off 10% of its 3,000-strong workforce, marking the second time it has done so this year. It is also pulling out of Germany as it tries to move faster towards profitability. Meanwhile peer Babylon has seen its value fall 20-fold.
Unlike the majority of his peers, Laurent Pochat-Cottilloux, the CEO of AXA Life and Health Reinsurance, isn’t convinced insurance will lead the charge towards prevention.
Both for-profit and public healthcare operators in Poland have been struggling to cope after a large influx of Ukrainian refugees. HBI speaks to contacts in Poland to find out more.
Click here to download your Deals+Insights briefing for November 2022 November sees Orpea forced to take drastic steps to fix its finances within four months, $13bn of private healthcare opportunities in Saudi Arabia, health care M&A slowing as concerns about debt rise, and German hospitals facing insolvency as the government swings away from inpatient treatment. […]
HBI chats with Paresh Patel, the new CEO of UK-based OCL Vision and former MD of UK, Czechia and Poland-based ophthalmology platform Optegra, about his new role, and the ophthalmology market in general.
It's no secret that the diagnostic labs sector benefitted immensely from testing during the Covid pandemic. But now that 2021 revenue figures are available for many of the largest groups, it is clear that the scale of the testing windfall has been larger than anyone in the sector imagined.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
